Clinical Trials Directory

Trials / Completed

CompletedNCT05666362

Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening

Hemodynamic Response Of Premature Brain To Pain During Retinopathy Of Prematurity Screening: A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
4 Weeks – 12 Weeks
Healthy volunteers
Not accepted

Summary

Study of cerebral hemodynamic changes in preterm infant and the effect of topical anesthetic eye drops ( benoxinate hydrochloride 0.4% ) on PIPP score and cerebral hemodynamic changes during fundus examination in neonates with gestational age ≤ 34 weeks or birth weight ≤ 2.000 Kg regardless their gestational age , after postnatal day 28.

Conditions

Interventions

TypeNameDescription
DRUGbenoxinate hydrochloride 0.4% groupThey will receive benoxinate hydrochloride 0.4% immediately before fundus
DRUGsaline 0.9% .They will receive saline 0.9% before fundus examination in each eye .

Timeline

Start date
2023-01-20
Primary completion
2024-12-20
Completion
2025-01-15
First posted
2022-12-27
Last updated
2025-02-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05666362. Inclusion in this directory is not an endorsement.

Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening (NCT05666362) · Clinical Trials Directory